Cargando…
Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application
The heart is one of the organs most vulnerable to sepsis. This review describes the general characteristics of sepsis-induced cardiomyopathy and the main pathogenesis of myocardial dysfunction in sepsis. Levosimendan is a novel drug for treatment of sepsis-induced myocardial dysfunction. This review...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567749/ https://www.ncbi.nlm.nih.gov/pubmed/30958071 http://dx.doi.org/10.1177/0300060519837103 |